2.10

9.87% -0.23

Terns Pharmaceuticals Inc (TERN)

Overview News Price History Option Chain Financials Discussions Forecast

Terns Pharmaceuticals Inc stock is traded at $2.10, with a volume of 1.44M. It is down -9.87% in the last 24 hours and down -40.17% over the past month. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Previous Close:

$2.33

Open:

$2.24

24h Volume:

1.44M

Relative Volume:

1.24

Market Cap:

$183.33M

Revenue:

Net Income/Loss:

$-95.90M

P/E Ratio:

-1.5909

EPS:

-1.32

Net Cash Flow:

$-79.09M

1W Performance:

-28.08%

1M Performance:

-40.17%

6M Performance:

-74.61%

1Y Performance:

-61.75%

1-Day Range:

$2.08

$2.29

1-Week Range:

$2.08

$2.88

52-Week Range:

$2.08

$11.40

Terns Pharmaceuticals Inc Stock (TERN) Company Profile

Name

Terns Pharmaceuticals Inc

Sector

Healthcare (1162)

Industry

Biotechnology (673)

Phone

650-525-5535 EXT.101

Address

1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

TERN's Discussions on Twitter

Compare TERN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TERN Terns Pharmaceuticals Inc	2.10	183.33M	0	-95.90M	-79.09M	-1.32
VRTX Vertex Pharmaceuticals Inc	474.62	121.88B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	573.45	62.69B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	555.11	33.86B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	235.74	30.51B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	238.51	25.69B	3.81B	-644.79M	-669.77M	-6.24

Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-28-25	Initiated	William Blair	Mkt Perform
Oct-31-24	Initiated	Oppenheimer	Outperform
Jun-22-23	Initiated	Mizuho	Buy
Jun-07-23	Initiated	Jefferies	Buy
May-31-23	Initiated	ROTH MKM	Buy
May-08-23	Initiated	BMO Capital Markets	Outperform
Feb-14-23	Initiated	JMP Securities	Mkt Outperform
Feb-07-23	Initiated	UBS	Buy
Sep-12-22	Initiated	H.C. Wainwright	Neutral
Sep-14-21	Resumed	Goldman	Buy
Mar-02-21	Initiated	Cowen	Outperform
Mar-02-21	Initiated	Goldman	Buy
Mar-02-21	Initiated	JP Morgan	Overweight

View All

Terns Pharmaceuticals Inc Stock (TERN) Latest News

Apr 03, 2025

Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN) - Yahoo Finance

Apr 03, 2025

Apr 02, 2025

Terns pharmaceuticals chief medical officer sells $2,365 in stock - Investing.com Australia

Apr 02, 2025

Terns Pharmaceuticals Reports Inducement Grant To New Employees Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 02, 2025

Terns Pharmaceuticals stock hits 52-week low at $2.5 By Investing.com - Investing.com South Africa

Apr 02, 2025

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Apr 02, 2025

Terns Pharmaceuticals Attracts Top Talent with 611,000-Share Equity Package - Stock Titan

Apr 02, 2025

Terns Pharmaceuticals stock hits 52-week low at $2.5 - Investing.com India

Apr 02, 2025

Apr 01, 2025

Terns Pharmaceuticals stock hits 52-week low at $4.16 - MSN

Apr 01, 2025

Mar 31, 2025

Insider Purchases Worth US$5.17m See Losses As Terns Pharmaceuticals Market Value Drops To US$255m - simplywall.st

Mar 31, 2025

HighTower Advisors LLC Invests $468,000 in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 31, 2025

Charles Schwab Investment Management Inc. Raises Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 31, 2025

Mar 28, 2025

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $18.30 Average Price Target from Analysts - Defense World

Mar 28, 2025

Mar 27, 2025

Terns Pharmaceuticals Reports 2024 Progress and Outlook - TipRanks

Mar 27, 2025

Mar 26, 2025

Terns Pharmaceuticals stock hits 52-week low at $3.08 By Investing.com - Investing.com South Africa

Mar 26, 2025

All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy - MSN

Mar 26, 2025

Terns Pharmaceuticals stock hits 52-week low at $3.08 - Investing.com

Mar 26, 2025

Mar 25, 2025

Bank of New York Mellon Corp Raises Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 25, 2025

Mar 24, 2025

Connor Clark & Lunn Investment Management Ltd. Boosts Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 24, 2025

Mar 23, 2025

Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Perform Rating from William Blair - Defense World

Mar 23, 2025

Mar 20, 2025